FIELD: organic chemistry, medicine.
SUBSTANCE: invention relates to a novel chemical compound, namely, to biologically active compound of the formula (I): possessing anti-arrhythmic activity and representing 5'-bromolappaconitine hydrobromide. Toxicity of this compound is by 4.8-fold less toxic as compared with analog used in medicinal practice and representing lappaconitine hydrobromide. Proposed compound possesses the expressed anti-arrhythmic activity in models with calcium chloride and adrenaline arrhythmia and provides the complete blocking both types of arrhythmia after administration of the dose that is 10-fold less of the therapeutic dose of lappaconitine hydrobromide.
EFFECT: improved and valuable medicinal properties of compound.
2 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
N-(BETA-HYDROXYETHYL)-CYTISINE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228179C2 |
NON-6-ENE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228334C2 |
FLUORATED 4-FURFURYL-3,4-DIHYDRO-2H-BENZO[1,4]THIAZINE-1,1-DIOXIDES WITH HIGH ARRYTHMIC ACTIVITY | 2016 |
|
RU2626239C1 |
THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
5-AMINO-EXO-3-AZATRICYCLO[5.2.1.0]-DECAN-4-ONE HAVING ANTI-ARRHYTHMIC, ANTI-INFLAMMATION, ANALGESIC, AND NOOTHROPIC ACTIVITY | 2005 |
|
RU2281938C1 |
DI-3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHNYL)-2-HYDROXY-1-(N ISOPOPYLAMINO)PROPANE SUCCINATE WITH ANTIARRHYTMIC ACTIVITY | 2008 |
|
RU2396248C1 |
(1-HYDROXY-4,5-DIMETHYL-1H-IMIDAZOL-2-YL)(PHENYL)METHANONOXIME EXHIBITING ANTIARRHYTHMIC PROPERTIES | 2012 |
|
RU2478622C1 |
ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
ANTIARRHYTHMIC DRUG BASED ON HYBRID MOLECULES OF AMLODIPINE WITH (7-METHOXICUMARIN-4-YL)ACETIC ACID | 2018 |
|
RU2678969C1 |
MEDICATION FOR ARTERIAL HYPERTENSION AND CARDIAC DYSRHYTHMIA TREATMENT | 2008 |
|
RU2391980C1 |
Authors
Dates
2007-03-20—Published
2005-08-29—Filed